Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121

Human Gene Therapy

Volumn 10, Issue 8, 1999, Pages 1331-1348

  Patel, Shailen R ^a,b   Lee, Leonard Y ^a,b   Mack, Charles A ^a,b   Polce, Dean R ^a,b   El Sawy, Tarek ^a,b   Hackett, Neil R ^a   Ilercil, Arzu ^b   Jones, Erica C ^b   Hahn, Rebecca T ^b   Isom, O Wayne ^b   Rosengart, Todd K ^b   Crystal, Ronald G ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; LEUKOCYTE COUNT; LIVER HISTOLOGY; LIVER LEVEL; MALE; MOUSE; MYOCARDITIS; NONHUMAN; SURVIVAL; SWINE; TISSUE NECROSIS;

ADENOVIRUSES, HUMAN; ANIMALS; CONSUMER PRODUCT SAFETY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELIAL GROWTH FACTORS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOLOGIC TESTS; HUMANS; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SWINE; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ADENOVIRIDAE; AMEROIDEA; ANIMALIA; MURINAE; SUIDAE; SUS SCROFA;

EID: 0033587180     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018012     Document Type: Article

References (72)

1. ADESANYA, M.R., REDMAN, R.S., BAUM, B.J., and O'CONNELL, B.C. (1996). Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7, 1085-1093.
2. BANAI, S., JAKLITSCH, M.T., CASSCELLS, W., SHOU, M., SHRIVASTAV, S., CORREA, R., EPSTEIN, S.E., and UNGER, E.F. (1991). Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 69, 76-85.
3. BANAI, S., JAKLITSCH, M.T., SHOU, M., LAZAROUS, D.F., SCHEINOWITZ, M., BIRO, S., EPSTEIN, S.E., and UNGER, E.F. (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2189.
4. BARLEON, B., SOZZANI, S., ZHOU, D., WEICH, H.A., MANTOVANI, A., and MARME, D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
5. BAUMGARTNER, I., MAGNER, M., PIECZEK, A.M., and ISNER, J.M. (1997). Clinical evidence that vascular endothelial growth factor enhances vascular permeability. Circulation 96, 1-491.
6. BAUTERS, C., ASAHARA, T., ZHENG, L.P., TAKESHITA, S., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1995). Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21, 314-324. [Discussion, pp. 324-325]
7. BLANCHARD, K.T., and BOEKELHEIDE, K. (1997). Adenovirus-mediated gene transfer to rat testis in vivo. Biol. Reprod. 56, 495-500.
8. BRODY, S.L., METZGER, M., DANEL, C., ROSENFELD, M.A., and CRYSTAL, R.G. (1994). Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821-836.
9. BROWN, L.F., YEO, K.T., BERSE, B., YEO, T.K., SENGER, D.R., DVORAK, H.F., and VAN DE WATER, L. (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379.
10. CHLEBOUN, J.O., MARTINS, R.N., MITCHELL, C.A., and CHIRILA, T.V. (1992). BFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem. Biophys. Res. Commun. 185, 510-516.
11. CLAUSS, M., WEICH, H.A., BREIER, G., KNIES, U., ROCKL, W., WALTENBERGER, J., and RISAU, W. (1996). The vascular endothelial growth factor receptor flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17629-17634.
12. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
13. GVVEGF121.10) containing the VEGF121 cDNA to the ische;mie myocardium of individuals with life threatening diffuse coronary artery disease. RAC Report # 9711221. (Office of Recombinant DNA Activities, National Institutes of Health, Bethesda, MD). 120892-7052]
14. DETMAR, M., BROWN, L.F., CLAFFEY, K.P., YEO, K.T., KOCHER, O., JACKMAN, R.W., BERSE, B., and DVORAK, H.F. (1994). Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146.
15. DVORAK, H.F., BROWN, L.F., DETMAR, M., and DVORAK, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
16. ENGLER, D.A. (1996). Use of vascular endothelial growth factor for therapeutic angiogenesis. Circulation 94, 1496-1498.
17. FAVA, R.A., OLSEN, N.J., SPENCER-GREEN, G., YEO, K.T., YEO, T.K., BERSE, B., JACKMAN, R.W., SENGER, D.R., DVORAK, H.F., and BROWN, L.F. (1994). Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180, 341-346.
18. FERRARA, N., HOUCK, K.A., JAKEMAN, L.B., WINER, J., and LEUNG, D.W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell Biochem. 47, 211-218.
19. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
20. FOLKMAN, J., and SHING, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
21. HARADA, K., GROSSMAN, W., FRIEDMAN, M., EDELMAN, E.R., PRASAD, P.V., KEIGHLEY, C.S., MANNING, W.J., SELLKE, F.W., and SIMONS, M. (1994). Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94, 623-630.
22. HARADA, K., FRIEDMAN, M., LOPEZ, J.J., WANG, S.Y., LI, J., PRASAD, P.V., PEARLMAN, J.D., EDELMAN, E.R., SELLKE, F.W., and SIMONS, M. (1996). Vascular endothelial growth factor administration in chronic myocardial ischemia. Am. J. Physiol. 270, H1791-H1802.
23. HARIAWALA, M.D., HOROWITZ, J.J., ESAKOF, D., SHERIFF, D.D., WALTER, D.H., KEYT, B., ISNER, J.M., and SYMES, J.F. (1996). VEGF improves myocardial blood flow but produces edrf-mediated hypotension in porcine hearts. J. Surg. Res. 63, 77-82.
24. HERSH, J., CRYSTAL, R.G., and BEWIG, B. (1995). Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
25. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. U.S.A. 90, 2812-2816.
26. HOCKEL, M., SCHLENGER, K., DOCTROW, S., KISSEL, T., and VAUPEL, P. (1993). Therapeutic angiogenesis. Arch. Surg. 128, 423-429.
27. HORRIGAN, M.C., MACISAAC, A.I., NICOLINI, F.A., VINCE, D.G., LEE, P., ELLIS, S.G., and TOPOL, E.J. (1996). Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation 94, 1927-1933.
28. HOUCK, K.A., FERRARA, N., WINER, J., CACHIANES, G., LI, B., and LEUNG, D.W. (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
29. HUARD, J., LOCHMULLER, H., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1995). The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2, 107-115.
30. KAJIWARA, K., BYRNES, A.P., CHARLTON, H.M., WOOD, M.J., and WOOD, K.J. (1997). Immune responses to adenoviral vectors during gene transfer in the brain. Hum. Gene Ther. 8, 253-265.
31. KASS-EISLER, A., FALCK-PEDERSEN, E., ELFENBEIN, D.H., ALVIRA, M., BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
32. KASS-EISLER, A., LEINWAND, L., GALL, J., BLOOM, B., and FALCK-PEDERSEN, E. (1996). Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther. 3, 154-162.
33. LANDAU, C., JACOBS, A.K., and HAUDENSCHILD, C.C. (1995). Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am. Heart J. 129, 924-931.
34. LAZAROUS, D.F., SHOU, M., SCHEINOWITZ, M., HODGE, E., THIRUMURTI, V., KITSIOU, A.N., STIBER, J.A., LOBO, A.D., HUNSBERGER, S., GUETTA, E., EPSTEIN, S.E., and UNGER, E.F. (1996). Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074-1082.
35. LEUNG, D.W., CACHIANES, G., KUANG, W.J., GOEDDEL, D.V., and FERRARA, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
36. MACK, C.A., MAGOVERN, C.J., BUDENBENDER, K.T., PATEL, S.R., SCHWARZ, E.A., ZANZONICO, P., FERRIS, B., SANBORN, T., ISOM, P., ISOM, O.W., CRYSTAL, R.G., and ROSENGART, T.K. (1998a). Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. 27, 699-709.
37. MACK, C.A., PATEL, S.R., SCHWARZ, E.A., ZANZONICO, P., HAHN, R.T., ILERCIL, A., DEVEREUX, R.B., GOLDSMITH, S.J., CHRISTIAN, T.F., SANBORN, T.A., KOVESDI, I., HACKETT, N., ISOM, O.W., CRYSTAL, R.G., and ROSENGART, T.K. (1998b). Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115, 168-176. [Discussion pp. 176-177]
38. MAGOVERN, C.J., MACK, C.A., ZHANG, J., ROSENGART, T.K., ISOM, O.W., and CRYSTAL, R.G. (1997). Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum. Gene Ther. 8, 215-227.
39. MASTRANGELI, A., HARVEY, B.C., YAO, J., WOLFF, G., KOVESDI, I., CRYSTAL, R.G., and FALCK-PEDERSEN, E. (1996). "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7, 79-87.
40. MCCLANE, S.J., HAMILTON, T.E., BURKE, C.V., and RAPER, S.E. (1997). Functional consequences of adenovirus-mediated murine pancreatic gene transfer. Hum. Gene Ther. 8, 739-746.
41. MICHOU, A.I., SANTORO, L., CHRIST, M., JULLIARD, V., PAVIRANI, A., and MEHTALI, M. (1997). Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4, 473-482.
42. MUHLHAUSER, J., JONES, M., YAMADA, I., CIRIELLI, C., LEMARCHAND, P., GLOE, T.R., BEWIG, B., SIGNORETTI, S., CRYSTAL, R.G., and CAPOGROSSI, M.C. (1996). Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3, 145-153.
43. MUROHARA, T., HOROWITZ, J.R., SILVER, M., TSURUMI, Y., CHEN, D., SULLIVAN, A., and ISNER, J.M. (1998). Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97, 99-107.
44. NEWMAN, K.D., DUNN, P.F., OWENS, J.W., SCHULICK, A.H., VIRMANI, R., SUKHOVA, G., LIBBY, P., and DICHEK, D.A. (1995). Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J. Clin. Invest. 96, 2955-2965.
45. PU, L.Q., SNIDERMAN, A.D., BRASSARD, R., LACHAPELLE, K.J., GRAHAM, A.M., LISBONA, R., and SYMES, J.F. (1993). Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88, 208-215.
46. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
47. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
48. ROSENGART, T.K., BUDENBENDER, K.T., DUENAS, M., MACK, C.A., ZHANG, Q.X., and ISOM, O.W. (1997). Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J. Vasc. Surg. 26, 302-312.
49. ROSENGART, T.K., PATEL, S.R., and CRYSTAL, R.G. (1999). Therapeutic angiogenesis: Protein and gene therapy delivery strategies. J. Cardiovasc. Risk 8, 29-40.
50. SCHOWALTER, D.B., MEUSE, L., WILSON, C.B., LINSLEY, P.S., and KAY, M.A. (1997). Constitutive expression of murine ctla4ig from a recombinant adenovirus vector results in prolonged transgene expression. Gene Ther. 4, 853-860.
51. SCHUMACHER, B., PECHER, P., VON SPECHT, B.U., and STEGMANN, T. (1998). Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97, 645-650.
52. SELLKE, F.W., WANG, S.Y., FRIEDMAN, M., HARADA, K., EDELMAN, E.R., GROSSMAN, W., and SIMONS, M. (1994). Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. 267, H1303-H1311.
53. SELLKE, F.W., LI, J., STAMLER, A., LOPEZ, J.J., THOMAS, K.A., and SIMONS, M. (1996). Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120, 182-188.
54. SHIBUYA, M., YAMAGUCHI, S., YAMANE, A., IKEDA, T., TOJO, A., MATSUSHIME, H., and SATO, M. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524.
55. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDLETON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780.
56. SIMONS, M., and WARE, J.A. (1996). Food for starving hearts. Nature Med. 2, 519-520.
57. SONG, W., KONG, H.L., TRAKTMAN, P., and CRYSTAL, R.G. (1997). Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum. Gene Ther. 8, 1207-1217.
58. SPRINGER, M.L., CHES, A., KRAFT, P.E., and BLAU, H.M. (1998). Myoblast-mediated gene delivery of constitutively expressed VEGF results in uncontrolled endothelial cell hyperplasia and hemangioma formation. In American Society of Gene Therapy, 1st Annual Meeting Washington, D.C., May 28-31, p. 113a.
59. SVENSSON, E.C., BLACK, H.B., DUGGER, D.L., TRIPATHY, S.K., GOODWASSER, E., HAO, Z., CHU, L., and LEIDEN, J.M. (1997). Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum. Gene Ther. 8, 1797-1806.
60. TAKESHITA, S., ROSSOW, S.T., KEARNEY, M., ZHENG, L.P., BAUTERS, C., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1995). Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J. Pathol. 147, 1649-1660.
61. TAKESHITA, S., TSURUMI, Y., COUFFINAHL, T., ASAHARA, T., BAUTERS, C., SYMES, J., FERRARA, N., and ISNER, J.M. (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487-501.
62. TERMAN, B.I., DOUGHER-VERMAZEN, M., CARRION, M.E., DIMITROV, D., ARMELLINO, D.C., GOSPODAROWICZ, D., and BOHLEN, P. (1992). Identification of the kdr tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586.
63. THOMAS, K.A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271, 603-606.
64. TISCHER, E., GOSPODAROWICZ, D., MITCHELL, R., SILVA, M., SCHILLING, J., LAU, K., CRISP, T., FIDDES, J.C., and ABRAHAM, J.A. (1989). Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun. 165, 1198-1206.
65. TOWNSON, S., LAGERCRANTZ, J., GRIMMOND, S., SILINS, G., NORDENSKJOLD, M., WEBER, G., and HAYWARD, N. (1996). Characterization of the murine VEGF related factor gene. Biochem. Biophys. Res. Commun. 220, 922-928.
66. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996a). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-detective adenovirus vectors. Nature Med. 2, 545-550.
67. TRIPATHY, S.K., SVENSSON, E.C., BLACK, H.B., GOLDWASSER, E., MARGALITH, M., HOBART, P.M., and LEIDEN, J.M. (1996b). Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. U.S.A. 93, 10876-10880.
68. UNGER, E.F., BANAI, S., SHOU, M., LAZAROUS, D.F., JAKLITSCH, M.T., SCHEINOWITZ, M., CORREA, R., KLINGBEIL, C., and EPSTEIN, S.E. (1994). Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266, H1588-H1595.
69. WILSON, J.M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187.
70. WORGALL, S., WOLFF, G., FALCK-PEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
71. YANAGISAWA-MIWA, A., UCHIDA, Y., NAKAMURA, F., TOMARU, T., KIDO, H., KAMIJO, T., SUGIMOTO, T., KAJI, K., UTSUYAMA, M., KURASHIMA, C., and ITO, H. (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257, 1401-1403.
72. YANG, R., THOMAS, G.R., BUNTING, S., KO, A., FERRARA, N., KEYT, B., ROSS, J., and JIN, H. (1996). Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol. 27, 838-844.